Both European Chemicals Agency Committees Back a Ban on Octocrylene in Sunscreens and Other Cosmetics
Both scientific committees of the European Chemicals Agency now back the proposed European Union ban on octocrylene in finished cosmetic products, including sunscreens. It is not yet law; the European Commission's decision is pending. The Committee for Risk Assessment calls octocrylene's transformation product benzophenone "carcinogenic and suspected endocrine disruptor". Octocrylene is still used in Australian sunscreens.

Both scientific committees of the European Chemicals Agency have backed the proposed ban on octocrylene in finished cosmetic products, including sunscreens. The Committee for Risk Assessment found the proposal "is the most appropriate Union wide measure to address the identified risk", and the Committee for Socio-economic Analysis reached the same conclusion (European Chemicals Agency, 2026, p. 6). The Australian Sunscreen Council is calling for octocrylene to be banned in Australian sunscreen, where it is still used (Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026, item 3550).
The committees' final opinion is now published on the European Chemicals Agency's restriction record. The proposed ban is not yet law. The European Commission's decision is pending.
What the committees backed
France proposed the restriction (European Chemicals Agency, 2026, p. ii). The opinion records that octocrylene, spelt "octocrilene" in European Union documents, is "used as a UV (mainly UVB) filter in finished cosmetic products that offer sun protection, including primary sunscreens" (European Chemicals Agency, 2026, p. 7). The opinion's summary of the proposal says that under it, "octocrilene would no longer perform its intended functions, effectively resulting in the discontinuation of its use in cosmetic products" (European Chemicals Agency, 2026, p. 8). "The restriction shall apply 24 months after its entry into force" (European Chemicals Agency, 2026, p. 6).
The Committee for Risk Assessment states: "RAC considers that the restriction proposed by the Dossier Submitter on octocrilene is the most appropriate Union wide measure to address the identified risk in terms of the effectiveness in reducing the risk, practicality and monitorability" (European Chemicals Agency, 2026, p. 6). Its opinion "was adopted by consensus" on 4 June 2026 (European Chemicals Agency, 2026, pp. ii–iii).
The Committee for Socio-economic Analysis states that the restriction "is the most appropriate Union wide measure to address the identified risks, as concluded by RAC" (European Chemicals Agency, 2026, p. 6). Its opinion was adopted on 16 September 2026 "by consensus of all members having the right to vote" (European Chemicals Agency, 2026, p. iii).
The committees' case is environmental. The Committee for Socio-economic Analysis agrees "that Union wide action is needed to address the environmental risks associated with the placing on the market of octocrilene in finished cosmetic products" (European Chemicals Agency, 2026, p. 11). The Committee for Risk Assessment explains that its text "focuses on environmental hazards as human health hazards (such as carcinogenicity of the transformation product benzophenone) of cosmetic products are assessed under the Cosmetic Products Regulation (CPR)" (European Chemicals Agency, 2026, p. 15).
Benzophenone
The Committee for Risk Assessment lists as an uncertainty "the impact of formation of (carcinogenic and suspected endocrine disruptor) benzophenone in octocrilene as sunscreens get older" (European Chemicals Agency, 2026, p. 77). It notes that "benzophenone is banned in cosmetics through Annex II of the Cosmetic Products Regulation" (European Chemicals Agency, 2026, p. 78).
Australia
Octocrylene is still used in Australian sunscreens. Australia's medicines regulator, the Therapeutic Goods Administration (TGA), lists it as a permitted sunscreen ingredient (Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026, item 3550).
What the Australian Sunscreen Council is calling for
The Australian Sunscreen Council points to TGA FOI 26-2156, which revealed the regulator's own May 2025 safety review states: "Benzophenone, an important impurity and degradant of octocrylene, is considered to be genotoxic, carcinogenic and shown to disrupt endocrine signalling" (Therapeutic Goods Administration [TGA], 2025, p. 54 of 74), and "Systemic absorption of octocrylene was demonstrated in recent randomised clinical trials following dermal application" (TGA, 2025, p. 53 of 74). The Council is calling for octocrylene to be banned in Australian sunscreen.
Non-nano zinc oxide is the only broad-spectrum UV filter that is reef safe and Generally Recognized As Safe and Effective (GRASE) by the US FDA (National Oceanic and Atmospheric Administration [NOAA], n.d.; National Park Service [NPS], n.d.; U.S. Food and Drug Administration [FDA], 2019, p. 6206; Beasley & Meyer, 2010; Hanrahan, 2012). On its own it protects across the full UVA and UVB range, including long UVA (Beasley & Meyer, 2010; Hanrahan, 2012).
The United States (FDA) now classifies bemotrizinol as generally recognized as safe and effective for over-the-counter sunscreens, under conditions set in its June 2026 final order (FDA, 2026, p. 8). The final order says "FDA concludes that bemotrizinol is GRASE for use as an active ingredient in OTC sunscreen drug products under the conditions set forth in Section IX of this document, and other applicable requirements." (FDA, 2026, p. 8). In its December 2025 proposed order, the FDA described bemotrizinol as exhibiting "high photostability and broad-spectrum coverage across the UVB (280 to 320 nanometers (nm)) and UVA (320 to 400 nm) ranges" (FDA, 2025, p. 5).
Other sun protection
Sunscreen is one part of sun protection. Cancer Council Australia says "Sunscreen is not a suit of armour and should be used with the other four sun protection measures" (Cancer Council Australia, n.d.). Its advice is to wear sun-protective clothing: "Choose clothing that covers as much skin as possible (think shirts with long sleeves)." Some clothing "may carry an ultraviolet protection factor (UPF), which is a guarantee of how much UV protection a fabric provides" (Cancer Council Australia, n.d.). Add a "broad-brimmed hat", "Seek shade" and wear "close-fitting wraparound sunglasses, that meet Australian Standards" (Cancer Council Australia, n.d.). The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) says "There is more to sun protection than just sunscreen. No sunscreen provides complete protection against UVR" (ARPANSA, n.d.).
About the Australian Sunscreen Council
The Australian Sunscreen Council is a registered Australian charity dedicated to improving the health of everyday Australians through UV education, research and evidence-based sun safety initiatives.
As Australia’s peak industry body for sunscreen safety, the Council works with scientists, medical professionals, industry experts and policymakers to advance sunscreen safety, support independent research, improve public understanding of UV exposure and promote stronger public-health standards.
ABN 64 692 134 982
Australian Sunscreen Council Editorial Team
The Council is supported by an Expert Group and may draw on advice from one or more members depending on the subject matter of a particular article, submission or publication. Members listed by the Council include (Australian Sunscreen Council, n.d.):
Dr Craig Downs, Executive Director, Haereticus Environmental Laboratory
Dr Russell Hills, cosmetic and laser dermatologist and Mohs specialist
Dr Denis Dudley, obstetrician-gynaecologist and endocrinologist
Dr Abhinandan “Rocky” Chowdhury, toxicologist
Dr Leslie Laquieze, sunscreen testing and photoprotection
Mgr. Mehrdad Mirzaei, pharmacist and photoprotection researcher
Joseph DiNardo, cosmetic toxicologist
Dr Alan Jones, skin cancer physician
Camila Biato Stopa, MSc, cosmetic scientist and pharmacist
Acknowledgment
Grok was used in the creation of this article. Always read the sunscreen label and use only as directed. Sunscreen is only one part of sun protection. Avoid prolonged sun exposure and wear protective clothing, hats, and eyewear.
References
Australian Radiation Protection and Nuclear Safety Agency. (n.d.). Sun protection using sunscreens. Retrieved November 1, 2026, from https://www.arpansa.gov.au/understanding-radiation/radiation-sources/more-radiation-sources/sun-protection-sunscreen
Australian Sunscreen Council. (n.d.). Scientific experts in sunscreen safety. Retrieved October 24, 2026, from https://www.australiansunscreencouncil.org/scientific-experts-sunscreen-safety
Beasley, D. G., & Meyer, T. A. (2010). Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen products. American Journal of Clinical Dermatology, 11(6), 413–421. https://doi.org/10.2165/11537050-000000000-00000
Cancer Council Australia. (n.d.). Protect your skin in five simple steps. Retrieved November 1, 2026, from https://www.cancer.org.au/save-your-skin/five-sunsmart-steps
European Chemicals Agency. (2026, September 16). Opinion on an Annex XV dossier proposing restrictions on octocrilene (ECHA/RAC/RES-O-0000007637-64-01/F; ECHA/SEAC/RES-O-0000007656-64-01/F) [Committee for Risk Assessment and Committee for Socio-economic Analysis]. https://chem.echa.europa.eu/api-activity-list/v1/restrictionProcess/documents?name=b8d969652bfd4fc7bea25fbe8d2beef4_rest_octocrilene_opinion_final_en.pdf
Hanrahan, J. R. (2012). Sunscreens. Australian Prescriber, 35(5), 148–151. https://doi.org/10.18773/austprescr.2012.068
National Oceanic and Atmospheric Administration. (n.d.). Skincare chemicals and marine life. National Ocean Service. Retrieved October 10, 2026, from https://oceanservice.noaa.gov/news/sunscreen-corals.html
National Park Service. (n.d.). Sunscreen. U.S. Department of the Interior. Retrieved October 10, 2026, from https://www.nps.gov/subjects/oceans/sunscreen.htm
Therapeutic Goods Administration. (2025, May). Safety review of seven active sunscreen ingredients (Version 1.0) [Released under FOI 26-2156, Document 4]. https://www.tga.gov.au/sites/default/files/2026-06/FOI%2026-2156.PDF
Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 (Cth). F2026L01382. https://www.legislation.gov.au/F2026L01382/latest/text
U.S. Food and Drug Administration. (2019, February 26). Sunscreen drug products for over-the-counter human use (Proposed rule, 84 Fed. Reg. 6204; Docket No. FDA-1978-N-0018). Federal Register. https://www.govinfo.gov/content/pkg/FR-2019-02-26/pdf/2019-03019.pdf
U.S. Food and Drug Administration. (2025, December 12). Proposed administrative order (OTC000039): Amending over-the-counter monograph M020: Sunscreen drug products for over-the-counter human use (Docket No. FDA-2025-N-6494; 90 Fed. Reg. 57765). https://www.accessdata.fda.gov/drugsatfda_docs/omuf/Order/supportDoc/OTC000039/Internal_Documents/2025.12.09%20ProposedOrder_BemotrizinolOTC000039_090026f88e15dab6.pdf
U.S. Food and Drug Administration. (2026, June 10). Final administrative order (OTC000039): Amending over-the-counter monograph M020: Sunscreen drug products for over-the-counter human use, and related information [Corrected version, August 10, 2026] (Docket No. FDA-2025-N-6494; 91 Fed. Reg. 35220). https://www.accessdata.fda.gov/drugsatfda_docs/omuf/Order/OTC000039_Final_Administrative_Order.pdf




